1. The X chromosome dosage compensation program during the development of cynomolgus monkeysIkuhiro Okamoto, Tomonori Nakamura, Kotaro Sasaki, Yukihiro Yabuta, Chizuru Iwatani, Hideaki Tsuchiya, Shin-ichiro Nakamura, Masatsugu Ema, Takuya Yamamoto, Mitinori SaitouScience 2021年11月19日10.1126/science.abd8887
2. Inherent genomic properties underlie the epigenomic heterogeneity of human induced pluripotent stem cellsShihori Yokobayashi, Yukihiro Yabuta, Masato Nakagawa, Keisuke Okita, Bo Hu, Yusuke Murase, Tomonori Nakamura, Guillaume Bourque, Jacek Majewski, Takuya Yamamoto, Mitinori SaitouCell Reports 2021年11月10.1016/j.celrep.2021.109909
3. In vitro reconstitution of the whole male germ-cell development from mouse pluripotent stem cells.Yukiko Ishikura, Hiroshi Ohta, Takuya Sato, Yusuke Murase, Yukihiro Yabuta, Yoji Kojima, Chika Yamashiro, Tomonori Nakamura, Takuya Yamamoto, Takehiko Ogawa, Mitinori SaitouCell stem cell 2021年9月1日10.1016/j.stem.2021.08.005
4. Non-human primates as a model for human development.Tomonori Nakamura*, Kohei Fujiwara, Mitinori Saitou, Tomoyuki TsukiyamaStem cell reports 2021年5月11日10.1016/j.stemcr.2021.03.021、*責任著者
5. GATA transcription factors, SOX17 and TFAP2C, drive the human germ-cell specification program.Yoji Kojima, Chika Yamashiro, Yusuke Murase, Yukihiro Yabuta, Ikuhiro Okamoto, Chizuru Iwatani, Hideaki Tsuchiya, Masataka Nakaya, Tomoyuki Tsukiyama, Tomonori Nakamura, Takuya Yamamoto, Mitinori SaitouLife science alliance 2021年5月10.26508/lsa.202000974
6. Capturing human trophoblast development with naive pluripotent stem cells in vitro.Shingo Io, Mio Kabata, Yoshiki Iemura, Katsunori Semi, Nobuhiro Morone, Atsutaka Minagawa, Bo Wang, Ikuhiro Okamoto, Tomonori Nakamura, Yoji Kojima, Chizuru Iwatani, Hideaki Tsuchiya, Belinda Kaswandy, Eiji Kondoh, Shin Kaneko, Knut Woltjen, Mitinori Saitou, Takuya Yamamoto, Masaki Mandai, Yasuhiro TakashimaCell stem cell 2021年4月5日10.1016/j.stem.2021.03.013